AUSTIN, Oct. 28, 2015 (GLOBE NEWSWIRE) -- LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, today announced that management will be participating in the following investment conferences in New York, NY:

  • Stephens Fall Investment Conference – Management will be presenting at 11:00 AM Eastern Time on Tuesday, November 10, 2015
  • Brean Capital Life Sciences Summit on Monday, November 16, 2015

About LDR Holding Corporation

LDR Holding Corporation is a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders. LDR's primary products are based on its exclusive Mobi® non-fusion and VerteBRIDGE® fusion technology platforms and are designed for applications in the cervical and lumbar spine. These technologies are designed to enable products that are less invasive, provide greater intra-operative flexibility, offer simplified surgical techniques and promote improved clinical outcomes for patients as compared to existing alternatives. In August 2013, LDR received approval from the U.S. Food and Drug Administration (FDA) for the Mobi-C® cervical disc replacement device, the first and only cervical disc replacement device to receive FDA approval to treat both one-level and two-level cervical disc disease. For more information regarding LDR Holding, visit www.ldr.com.

CONTACT: 
Robert McNamara
Executive Vice President and Chief Financial Officer
LDR Holding Corporation
512-344-3333

Matthew Norman
Director, Investor Relations
LDR Holding Corporation
512-344-3408